Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Jan;59(1):20-29.
doi: 10.1111/jcpp.12652. Epub 2016 Nov 21.

Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder

Khaled Saad  1 , Ahmed A Abdel-Rahman  2 , Yasser M Elserogy  2 , Abdulrahman A Al-Atram  3 , Amira A El-Houfey  4 , Hisham A-K Othman  5 , Geir Bjørklund  6 , Feiyong Jia  7 , Mauricio A Urbina  8   9 , Mohamed Gamil M Abo-Elela  10 , Faisal-Alkhateeb Ahmad  1 , Khaled A Abd El-Baseer  10 , Ahmed E Ahmed  10 , Ahmad M Abdel-Salam  11
Affiliations
Randomized Controlled Trial

Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder

Khaled Saad et al. J Child Psychol Psychiatry. 2018 Jan.

Retraction in

Abstract

Background: Autism spectrum disorder (ASD) is a frequent developmental disorder characterized by pervasive deficits in social interaction, impairment in verbal and nonverbal communication, and stereotyped patterns of interests and activities. It has been previously reported that there is vitamin D deficiency in autistic children; however, there is a lack of randomized controlled trials of vitamin D supplementation in ASD children.

Methods: This study is a double-blinded, randomized clinical trial (RCT) that was conducted on 109 children with ASD (85 boys and 24 girls; aged 3-10 years). The aim of this study was to assess the effects of vitamin D supplementation on the core symptoms of autism in children. ASD patients were randomized to receive vitamin D3 or placebo for 4 months. The serum levels of 25-hydroxycholecalciferol (25 (OH)D) were measured at the beginning and at the end of the study. The autism severity and social maturity of the children were assessed by the Childhood Autism Rating Scale (CARS), Aberrant Behavior Checklist (ABC), Social Responsiveness Scale (SRS), and the Autism Treatment Evaluation Checklist (ATEC).

Trial registration number: UMIN-CTR Study Design: trial number: UMIN000020281.

Results: Supplementation of vitamin D was well tolerated by the ASD children. The daily doses used in the therapy group was 300 IU vitamin D3/kg/day, not to exceed 5,000 IU/day. The autism symptoms of the children improved significantly, following 4-month vitamin D3 supplementation, but not in the placebo group. This study demonstrates the efficacy and tolerability of high doses of vitamin D3 in children with ASD.

Conclusions: This study is the first double-blinded RCT proving the efficacy of vitamin D3 in ASD patients. Depending on the parameters measured in the study, oral vitamin D supplementation may safely improve signs and symptoms of ASD and could be recommended for children with ASD. At this stage, this study is a single RCT with a small number of patients, and a great deal of additional wide-scale studies are needed to critically validate the efficacy of vitamin D in ASD.

Keywords: Autism spectrum disorder; children; clinical trial; vitamin D.

PubMed Disclaimer

Comment in

Publication types